Hardman & Co Research
Hardman & Co Research: Primary Health Properties (PHP): High security and
accelerating dividend growth
05-Aug-2019 / 14:12 GMT/BST
Hardman & Co Research: High security and accelerating dividend growth
90% of PHP's income is backed by the UK or Republic of Ireland (RoI)
governments. Occupancy consistently exceeds 99%. We are confident investors
will continue to seek out REITs with strong asset-class focus, particularly
categories that provide security of rising income. PHP achieves all this and
its dividend per share growth rate is accelerating as a result. In a total
contrast to the wider real estate market, rent reviews on PHP assets are
accelerating upwards. PHP's growth avenues are expanding. The March 2019
merger with MedicX Fund - as well as a GBP4m p.a. synergy efficiency and
additional investment assets of more than GBP800m - has added complementary
routes to purchase new assets.
Please click here for the full report:
https://www.hardmanandco.com/research/corporate-research/high-security-and-acc
elerating-dividend-growth/ [1]
To contact us: Contact:
Hardman & Co Mike Foster mf@hardmanandco.com
35 New Broad Street
London +44 20 7194 7633
EC2M 1NH
www.hardmanandco.com
Follow us on Twitter
@HardmanandCo
Hardman & Co Research can still be accessed for free after MiFID II. Please
click here [2] to read the statement.
About Hardman & Co: For the past 21 years Hardman has been producing
specialist research designed to improve investors' understanding of companies,
sectors, industries and investment securities. Our analysts are highly
experienced in their sectors, and have often been highly rated by professional
investors for their knowledge. Our focus is to raise companies' profiles
across the UK and abroad with outstanding research, investor engagement
programmes and advisory services. Some of our notes have been commissioned by
the company which is the subject of the note; this is clearly stated in the
disclaimer where this is the case.
Hardman Research Ltd, trading as Hardman & Co, is an appointed representative
of Capital Markets Strategy Ltd and is authorised and regulated by the
Financial Conduct Authority; our FCA registration number is 600843. Hardman
Research Ltd is registered at Companies House with number 8256259.
Our research is provided for the use of the professional investment community,
market counterparties and sophisticated and high net worth investors as
defined in the rules of the regulatory bodies. It is not intended to be made
available to unsophisticated retail investors. Anyone who is unsure of their
categorisation should consult their professional advisors. This research is
neither an offer, nor a solicitation, to buy or sell any security. Please read
the note for the full disclaimer.
Dissemination of a CORPORATE NEWS, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.
End of Announcement - EQS News Service
851983 05-Aug-2019
1: https://link.cockpit.eqs.com/cgi-bin/fncls.ssp?fn=redirect&url=9bf06491e1f83fda4195ee6d69f65940&application_id=851983&site_id=vwd&application_name=news
2: https://link.cockpit.eqs.com/cgi-bin/fncls.ssp?fn=redirect&url=5a632f52f80bd372265e4041a743aa1c&application_id=851983&site_id=vwd&application_name=news
(END) Dow Jones Newswires
August 05, 2019 09:12 ET (13:12 GMT)
© 2019 Dow Jones News
